[The modern view on the role of inflammatory factors in chronic heart failure and possibilities of pharmacological modification].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000638:Amiodarone / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D002097:C-Reactive Protein / Q000276:immunology*; D002227:Carbazoles / Q000627:therapeutic use; D000077261:Carvedilol; D002908:Chronic Disease; D016207:Cytokines / Q000276:immunology*; D000068800:Etanercept; D006333:Heart Failure / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D007074:Immunoglobulin G / Q000627:therapeutic use; D010431:Pentoxifylline / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011412:Propanolamines / Q000627:therapeutic use; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000894:Anti-Inflammatory Agents, Non-Steroidal; D002227:Carbazoles; D016207:Cytokines; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007074:Immunoglobulin G; D010975:Platelet Aggregation Inhibitors; D011412:Propanolamines; D018124:Receptors, Tumor Necrosis Factor; D014665:Vasodilator Agents; D000077261:Carvedilol; D002097:C-Reactive Protein; D000638:Amiodarone; D000068800:Etanercept; D010431:Pentoxifylline
Współczesne poglady na temat roli czynników zapalnych w niewydolności serca i mozliwości ich farmakologicznej modyfikacji.